Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (281-290 of 325) with videos related to

Pageof 33
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2P Seeman, K Ohara, C Ulpian, et al.
Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.
Casopis Lekaru Ceskych|April 26, 2006
[Mutations in tumor suppressor gene NBS1 in adult patients with malignancies]E Seemanová, J Hoch, J Herzogová, et al.
Brain Research. Molecular Brain Research|April 29, 1998
A human serotonin-7 receptor pseudogeneI H Qian, I Kusumi, C Ulpian, et al.
Brain Research. Molecular Brain Research|May 1, 1991
Visualization of a dopamine D1 receptor mRNA in human and rat brainG Mengod, M T Vilaró, H B Niznik, et al.
Neurogenetics|October 25, 2014
Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptomP Laššuthová, D Šafka Brožková, M Krůtová, et al.
Journal of Medicinal Chemistry|April 1, 1985
Novel photoaffinity label for the dopamine D2 receptor: synthesis of 4-azido-5-iodo-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl] benzamide (iodoazidoclebopride, IAC) and the corresponding 125I-labeled analogue (125IAC)J L Neumeyer, J H Guan, H B Niznik, et al.
The Journal of Biological Chemistry|November 7, 1998
A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerizationS R George, S P Lee, G Varghese, et al.
Journal of Neurogenetics|November 19, 2011
Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathyJ Haberlová, R Mazanec, P Ridzoň, et al.
Biochemical and Biophysical Research Communications|October 3, 1996
Dopamine D2 receptor dimers and receptor-blocking peptidesG Y Ng, B F O'Dowd, S P Lee, et al.
Pageof 33

Showing results (281-290 of 325) with videos related to

Sort By:
Pageof 33
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1993
Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2P Seeman, K Ohara, C Ulpian, et al.
Science (New York, N.Y.)|August 17, 1984
Bimodal distribution of dopamine receptor densities in brains of schizophrenicsP Seeman, C Ulpian, C Bergeron, et al.
Casopis Lekaru Ceskych|April 26, 2006
[Mutations in tumor suppressor gene NBS1 in adult patients with malignancies]E Seemanová, J Hoch, J Herzogová, et al.
Brain Research. Molecular Brain Research|April 29, 1998
A human serotonin-7 receptor pseudogeneI H Qian, I Kusumi, C Ulpian, et al.
Brain Research. Molecular Brain Research|May 1, 1991
Visualization of a dopamine D1 receptor mRNA in human and rat brainG Mengod, M T Vilaró, H B Niznik, et al.
Neurogenetics|October 25, 2014
Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptomP Laššuthová, D Šafka Brožková, M Krůtová, et al.
Journal of Medicinal Chemistry|April 1, 1985
Novel photoaffinity label for the dopamine D2 receptor: synthesis of 4-azido-5-iodo-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl] benzamide (iodoazidoclebopride, IAC) and the corresponding 125I-labeled analogue (125IAC)J L Neumeyer, J H Guan, H B Niznik, et al.
The Journal of Biological Chemistry|November 7, 1998
A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerizationS R George, S P Lee, G Varghese, et al.
Journal of Neurogenetics|November 19, 2011
Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathyJ Haberlová, R Mazanec, P Ridzoň, et al.
Biochemical and Biophysical Research Communications|October 3, 1996
Dopamine D2 receptor dimers and receptor-blocking peptidesG Y Ng, B F O'Dowd, S P Lee, et al.
Pageof 33